BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

18 articles for P Joshi

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Quinazoline derivatives as selective CYP1B1 inhibitors.EBI
Birla Institute of Technology
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.EBI
De Montfort University
6-Aryl substituted 4-(4-cyanomethyl) phenylamino quinazolines as a new class of isoform-selective PI3K-alpha inhibitors.EBI
Csir-Indian Institute of Integrative Medicine
A chromatography-free isolation of rohitukine from leaves of Dysoxylum binectariferum: Evaluation for in vitro cytotoxicity, Cdk inhibition and physicochemical properties.EBI
India Academy of Scientific & Innovative Research (Acsir)
Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents.EBI
India Academy of Scientific & Innovative Research (Acsir)
Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.EBI
Vertex Pharmaceuticals
A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.EBI
Virtua Drug
Discovery of Potent, Selective, and State-Dependent NaEBI
Lupin
5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.EBI
The University of Louisiana At Monroe
The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic.EBI
Roche Research Center
Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists.EBI
Roche Research Center
Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship.EBI
Csir-Indian Institute of Integrative Medicine
Biphenyl-4-carboxylic acid [2-(1H-indol-3-yl)-ethyl]-methylamide (CA224), a nonplanar analogue of fascaplysin, inhibits Cdk4 and tubulin polymerization: evaluation of in vitro and in vivo anticancer activity.EBI
De Montfort University
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.EBI
Csir - Indian Institute of Integrative Medicine
(E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent.EBI
De Montfort University
Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.EBI
De Montfort University
Analysis of saponins and phenolic compounds as inhibitors of a-carbonic anhydrase isoenzymes.BDB
Ege University
Fused pyrazole derivatives as novel ERK inhibitorsBDB
Merck Sharp & Dohme